FGF23 Is Endogenously Phosphorylated in Bone Cells
β Scribed by Lindberg, Iris; Pang, Hong Weng; Stains, Joseph P; Clark, David; Yang, Austin J; Bonewald, Lynda; Li, Kevin Z
- Book ID
- 127251988
- Publisher
- American Society for Bone and Mineral Research
- Year
- 2015
- Tongue
- English
- Weight
- 393 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0884-0431
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Parathyroid hormone (PTH) increases fibroblast growth factor receptorβ1 (FGFR1) and fibroblast growth factorβ2 (FGFβ2) expression in osteoblasts and the anabolic response to PTH is reduced in Fgf2β/β mice. This study examined whether candidate factors implicated in the anabolic response
## Abstract Besides numerous other factors, fibroblast growth factor receptor (FGFR) signaling is involved in fracture healing and bone remodeling. FGF23 is a phosphatonin produced by osteoblastic cells, which signals via FGFR1, thereby exerting effects in bone and kidney. We analyzed if serum FGF2
## Abstract The functional interaction between fibroblast growth factor 23 (FGFβ23) and Klotho in the control of vitamin D and phosphate homeostasis is manifested by the largely overlapping phenotypes of __Fgf23β__ and __Klothoβ__deficient mouse models. However, to date, targeted inactivation of FG